Pancreatic acinar cell carcinoma
MONDO:0006346An adenocarcinoma arising from the pancreas. It is characterized by the presence of relatively uniform malignant cells which form acinar patterns. It usually occurs during adulthood. Signs and symptoms include abdominal pain, weight loss, nausea, and diarrhea. It may metastasize to regional lymph nodes and the liver. A minority of patients develop lipase hypersecretion syndrome. This syndrome may be seen in patients with liver metastases and it is characterized by excessive secretion of lipase in the serum, polyarthralgia, and subcutaneous fat necrosis.
Also known as: Pancreatic acinar cell cancer, acinar cell adenocarcinoma of pancreas, acinar cell adenocarcinoma of the pancreas, acinar cell carcinoma of pancreas, acinar cell carcinoma of the pancreas, carcinoma of pancreatic acinar cell, pancreas acinar cell adenocarcinoma, pancreatic acinar cell adenocarcinoma
2895 clinical trials for this condition and its sub-types, 12 tagged with Pancreatic acinar cell carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Pancreatic acinar cell carcinoma
-
New drug cocktail shows promise against tough pancreatic cancer
Disease control CompletedThis completed phase 1/2 trial tested an experimental drug called Y101D combined with standard chemotherapy (gemcitabine and nab-paclitaxel) as a first treatment for 71 people with advanced pancreatic cancer. The goal was to find a safe dose and see if the combo helps shrink tumo…
Phase 1/2 • Sponsor: Wuhan YZY Biopharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Double-Dose chemo strategy shows promise against pancreatic cancer
Disease control CompletedThis study tested a combination of chemotherapy drugs given both before and after surgery for people with early-stage pancreatic cancer. The goal was to shrink the tumor before surgery and kill any remaining cancer cells afterward. 46 participants were enrolled to see if this app…
Phase 2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC